GO:0001587 Gq/11-coupled serotonin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001587 describes a molecular function in which serotonin binding activates the Gq/11 heterotrimeric G protein, triggering phospholipase C and raising inositol triphosphate (IP3) levels.
• The term is synonymous with 5-HT2 receptor activity and serotonin receptor activity coupled via Gq/11, and is distinct from Gs- or Gi/o-coupled serotonin receptors.
• Gq/11-coupled serotonin receptors can exhibit constitutive activity, enabling them to signal even without agonist and to transactivate co-expressed Gi/o-coupled receptors.
• Downstream signaling from these receptors intersects with growth-factor pathways such as HB-EGF/EGFR-ERK1/2-mTOR, linking serotonin to insulin resistance.
• Heteromeric receptor complexes, such as mGlu2-5-HT2A, demonstrate allosteric signaling that may contribute to schizophrenia pathophysiology.
• Dietary isoflavone metabolites can relax arteries and lower blood pressure, highlighting the pharmacological relevance of serotonergic and related Gq/11 signaling in vascular tone.
Description
Gq/11-coupled serotonin receptor activity (GO:0001587) is a molecular function that combines serotonin binding with signal transmission through the Gq/11 subunit of a heterotrimeric G protein complex, leading to phospholipase C activation and increased inositol triphosphate (IP3) levels. This activity is central to how serotonin modulates neuronal excitability, vascular tone, and endocrine responses, and it is a major target for neuropsychiatric and cardiovascular drugs. Researchers study this term to understand how a single neurotransmitter can produce diverse cellular outcomes depending on the receptor subtype and the G protein it couples to. The function is not merely a passive switch; constitutive activity and heteromeric receptor complexes add layers of regulation that influence disease phenotypes such as schizophrenia and metabolic disorders. Because Gq/11-coupled serotonin receptors can transactivate other signaling systems, they serve as a hub for crosstalk between serotonergic and growth-factor pathways. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0001587, its genes, mechanisms, and experimental models.
Gq/11-coupled serotonin receptor activity At A Glance
| GO ID | GO:0001587 |
|---|---|
| GO term | Gq/11-coupled serotonin receptor activity |
| Ontology | molecular_function |
| Synonym | 5-HT2 receptor activity; serotonin receptor activity, coupled via Gq/11 |
| Major function | Serotonin binding and signal transmission via Gq/11, activating phospholipase C and increasing IP3 |
| G protein subunit | Gq/11 (G alpha q/11 family) |
| Downstream effector | Phospholipase C, IP3, diacylglycerol, calcium |
| Constitutive activity | Possible; can enable signaling by co-expressed Gi/o-coupled receptors |
| Receptor family | Serotonin 5-HT2 receptor subtypes (e.g., 5-HT2A, 5-HT2B, 5-HT2C) |
What Is GO:0001587?
In simple terms, GO:0001587 is the activity of a serotonin receptor that, upon binding serotonin, activates the Gq/11 protein instead of Gs or Gi/o. This activation stimulates phospholipase C, which produces IP3 and diacylglycerol, leading to calcium release and protein kinase C activation. The term specifically requires coupling to the Gq/11 subunit of a cytoplasmic heterotrimeric G protein complex, and it is synonymous with 5-HT2 receptor activity and serotonin receptor activity coupled via Gq/11. It is a molecular function, not a biological process or cellular component, and it is defined by the signal-transducing capability of the receptor rather than by the identity of the receptor protein itself.
Why Is Gq/11-coupled serotonin receptor activity Important in Cell Biology?
GO:0001587 is important because it defines a major route by which serotonin exerts excitatory and modulatory effects in the brain, vasculature, and peripheral tissues, and because its dysregulation is implicated in schizophrenia, metabolic disease, and vascular disorders. The ability of Gq/11-coupled serotonin receptors to signal constitutively and to form heteromers with other receptors expands their pharmacological reach, making them key nodes for drug discovery and for understanding off-target effects. Moreover, crosstalk with growth-factor pathways such as HB-EGF/EGFR-ERK1/2-mTOR links this activity to insulin resistance, a hallmark of type 2 diabetes and metabolic syndrome. In the vasculature, serotonergic and related Gq/11 signaling influence arterial tone and blood pressure, as shown by isoflavone metabolites that relax arteries and decrease blood pressure in vivo. Thus, researchers studying this term can connect molecular mechanism to organismal physiology and disease.
• Defines a primary excitatory serotonin signaling mechanism via Gq/11 and phospholipase C.
• Enables constitutive, agonist-independent signaling that can transactivate Gi/o-coupled receptors.
• Links serotonin to growth-factor pathways such as HB-EGF/EGFR-ERK1/2-mTOR, contributing to insulin resistance.
• Forms heteromeric complexes (e.g., mGlu2-5-HT2A) with allosteric signaling relevant to schizophrenia.
• Influences vascular tone and blood pressure, as demonstrated by isoflavone metabolite effects on arteries.
• Provides a pharmacological target for antipsychotics, antidepressants, and cardiovascular agents.
• Serves as a model for understanding Gq/11-coupled receptor crosstalk and signal integration.
• Highlights the importance of receptor subtype and cellular context in serotonin action.
• Supports research into metabolic syndrome and type 2 diabetes via serotonin-growth factor crosstalk.
• Offers a basis for natural-product pharmacology, including isoflavone metabolites and arterial relaxation.
What Happens During Gq/11-coupled serotonin receptor activity?
Serotonin binding and receptor activation
In simple terms: Serotonin binds to the receptor, changing its shape so it can activate a G protein.
The function begins when serotonin binds to a Gq/11-coupled serotonin receptor, such as a 5-HT2 subtype, inducing a conformational change that allows the receptor to act as a guanine nucleotide exchange factor for the Gq/11 alpha subunit. This step is the defining event of GO:0001587, as it couples ligand recognition to intracellular signaling. Constitutive activity can occur even without agonist, enabling the receptor to signal basally and to influence co-expressed Gi/o-coupled receptors.
Gq/11 activation and phospholipase C stimulation
In simple terms: The activated G protein turns on an enzyme that makes signaling molecules.
Upon activation, the Gq/11 alpha subunit exchanges GDP for GTP and dissociates from the beta-gamma dimer, then stimulates phospholipase C. Phospholipase C hydrolyzes phosphatidylinositol 4,5-bisphosphate into diacylglycerol and inositol triphosphate (IP3), directly increasing IP3 levels as specified in the GO definition. This cascade is the core signal-transduction mechanism of GO:0001587.
Calcium release and downstream kinase activation
In simple terms: IP3 releases calcium inside the cell, which then activates many proteins.
IP3 binds to receptors on the endoplasmic reticulum, causing calcium release into the cytoplasm and activation of calcium-dependent enzymes and protein kinase C via diacylglycerol. These events propagate the serotonin signal to diverse cellular processes, including gene expression, secretion, and contraction. The increase in IP3 is a hallmark of Gq/11-coupled serotonin receptor activity and distinguishes it from Gs- or Gi/o-coupled serotonin signaling.
Crosstalk with growth-factor and heteromeric receptor systems
In simple terms: This receptor can talk to other receptors and growth-factor pathways.
Gq/11-coupled serotonin receptors can transactivate growth-factor pathways; for example, serotonin-induced HB-EGF mediates insulin resistance through EGFR-ERK1/2-mTOR signaling. They can also form heteromeric complexes with other G-protein-coupled receptors, such as mGlu2-5-HT2A, where allosteric interactions modulate signaling and may contribute to schizophrenia. These crosstalk mechanisms expand the functional output of GO:0001587 beyond canonical phospholipase C activation.
Physiological modulation of vascular tone
In simple terms: This signaling can relax blood vessels and lower blood pressure.
Serotonergic and related Gq/11 signaling influence arterial tone; isoflavone metabolites such as O-desmethylangolensin and (S)-equol relax isolated arteries ex vivo and decrease arterial blood pressure in vivo. This physiological readout demonstrates that GO:0001587-related pathways have systemic cardiovascular effects. The integration of receptor activity with vascular function highlights the translational importance of this molecular function.
Key Genes Involved in GO:0001587 Gq/11-coupled serotonin receptor activity
The following genes and proteins are central to Gq/11-coupled serotonin receptor activity, based on verified literature and established receptor pharmacology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HTR2A | 5-HT2A receptor, Gq/11-coupled serotonin receptor | Target for antipsychotics; heteromer studies in schizophrenia |
| HTR2B | 5-HT2B receptor, Gq/11-coupled serotonin receptor | Cardiovascular effects; vascular tone regulation |
| HTR2C | 5-HT2C receptor, Gq/11-coupled serotonin receptor | Metabolic and mood regulation; drug target |
| GNAQ | Gq alpha subunit, mediates phospholipase C activation | Core transducer of GO:0001587 |
| GNA11 | G11 alpha subunit, alternative Gq/11 transducer | Redundant signaling with GNAQ |
| PLCB1 | Phospholipase C beta 1, produces IP3 and DAG | Effector of Gq/11 signaling |
| PLCB2 | Phospholipase C beta 2, effector enzyme | Cell-type specific IP3 generation |
| PLCB3 | Phospholipase C beta 3, effector enzyme | Modulates calcium signaling |
| PLCB4 | Phospholipase C beta 4, effector enzyme | Neuronal signaling diversity |
| HBEGF | Heparin-binding EGF-like growth factor, mediates serotonin-induced insulin resistance | Links 5-HT to EGFR-ERK1/2-mTOR |
| EGFR | Epidermal growth factor receptor, transactivated by serotonin | Metabolic crosstalk target |
| ERK1/2 | Mitogen-activated protein kinases, downstream of EGFR | Mediates insulin resistance signaling |
| MTOR | mTOR kinase, integrates growth factor signals | Metabolic and translational control |
| GRM2 | mGlu2 receptor, forms heteromers with 5-HT2A | Allosteric signaling in schizophrenia |
| GNAI1 | Gi/o alpha subunit, co-expressed with Gq/11 receptors | Constitutive activity enables Gi/o signaling |
| GNAI2 | Gi/o alpha subunit, co-expressed with Gq/11 receptors | Signal integration |
| GNAI3 | Gi/o alpha subunit, co-expressed with Gq/11 receptors | Signal integration |
How Is Gq/11-coupled serotonin receptor activity Regulated?
Gq/11-coupled serotonin receptor activity is regulated at multiple levels. Constitutive activity of the receptor can enable signaling by co-expressed Gi/o-coupled receptors, meaning that the absence of agonist does not necessarily mean absence of signal. Heteromeric receptor complexes, such as mGlu2-5-HT2A, provide allosteric regulation where one receptor modulates the other's signaling, potentially contributing to schizophrenia. Downstream, the activity is integrated with growth-factor pathways: serotonin-induced HB-EGF activates EGFR-ERK1/2-mTOR, which can feed back on cellular metabolism and insulin sensitivity. Additionally, physiological states such as vascular tone can be modulated by dietary compounds; isoflavone metabolites relax arteries and decrease blood pressure, indicating that Gq/11-related serotonergic signaling is subject to pharmacological and nutritional regulation.
Gq/11-coupled serotonin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HTR2A | Schizophrenia, psychosis | Knockout or point-mutation cell models; heteromer studies |
| HTR2B | Cardiovascular tone, hypertension | Knock-in reporter or overexpression models |
| HTR2C | Metabolic syndrome, mood disorders | Knockout and point-mutation models |
| HBEGF | Insulin resistance, type 2 diabetes | Overexpression and knockout models |
| EGFR | Metabolic crosstalk, cancer | Point-mutation and knockout models |
Schizophrenia and neuropsychiatric disorders
Gq/11-coupled serotonin receptors, particularly 5-HT2A, are implicated in schizophrenia through heteromeric complex formation with mGlu2 receptors, which produces allosteric signaling changes that may contribute to disease pathophysiology. This heteromer-based mechanism provides a molecular explanation for how serotonergic and glutamatergic systems interact in psychosis. Targeting these complexes may offer novel therapeutic strategies beyond traditional antipsychotics.
Metabolic disease and insulin resistance
Serotonin signaling through Gq/11-coupled receptors can induce insulin resistance via HB-EGF-mediated activation of the EGFR-ERK1/2-mTOR pathway. This links serotonin activity to metabolic syndrome and type 2 diabetes, suggesting that receptor antagonists or pathway inhibitors could improve insulin sensitivity. The crosstalk between serotonin and growth-factor signaling is a promising area for metabolic drug discovery.
Cardiovascular disorders and vascular tone
Gq/11-coupled serotonin receptors contribute to vascular smooth muscle contraction and tone regulation; isoflavone metabolites that relax arteries and lower blood pressure in vivo demonstrate the physiological relevance of this pathway. Dysregulation of serotonergic signaling has been associated with hypertension and other cardiovascular conditions. Natural products and receptor-selective ligands may modulate this activity for therapeutic benefit.
Constitutive signaling and receptor crosstalk in disease
Constitutively active Gq/11-coupled receptors can enable signaling by co-expressed Gi/o-coupled receptors, potentially altering cellular responses in disease states. This constitutive activity may contribute to pathological signaling in conditions where receptor expression or G protein availability is altered. Understanding these mechanisms is important for drug development, as inverse agonists may be needed to suppress basal activity.
From Gq/11-coupled serotonin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of Gq/11-coupled serotonin receptor affect downstream IP3 signaling? | Knockout cell model (e.g., HTR2A KO) |
| Does a specific receptor mutation alter constitutive activity? | Point-mutation knock-in model |
| Can receptor heteromerization be visualized and modulated? | Tagged knock-in or knock-in reporter model |
| Does overexpression of the receptor enhance serotonin-induced insulin resistance? | Overexpression cell model |
| Which genes mediate vascular relaxation by isoflavone metabolites? | Knockout and overexpression models in vascular cells |
| How does Gq/11 signaling integrate with Gi/o pathways? | Co-expression knockout/knock-in models |
How to Study the Gq/11-coupled serotonin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| IP3 assay | Inositol triphosphate levels | Confirm Gq/11 coupling |
| Calcium imaging | Intracellular calcium release | Receptor activation and screening |
| Phospholipase C activity assay | Enzyme activity | Effector activation |
| Western blot for ERK1/2 | Kinase phosphorylation | Downstream signaling |
| BRET/FRET | Protein-protein interactions | Heteromer detection |
| Ex vivo arterial ring assay | Vascular relaxation | Cardiovascular pharmacology |
| Blood pressure telemetry | In vivo blood pressure | Physiological validation |
| Co-immunoprecipitation | Receptor complex formation | Allosteric signaling studies |
Measuring IP3 and calcium flux
Because GO:0001587 is defined by increased IP3 levels, researchers can use IP3 assays and calcium imaging to directly monitor receptor activity. These methods are essential for confirming that a given serotonin receptor couples to Gq/11 rather than Gs or Gi/o. Calcium flux assays are also useful for high-throughput screening of receptor ligands.
Phospholipase C and downstream kinase assays
Phospholipase C activity can be measured using substrate-based assays, and downstream kinases such as ERK1/2 can be assessed by Western blot. These readouts connect receptor activation to functional cellular outcomes, including insulin resistance pathways. Combining these assays with receptor-specific antagonists helps establish causality.
Heteromer and allosteric signaling studies
For heteromeric complexes such as mGlu2-5-HT2A, researchers use co-immunoprecipitation, BRET, or FRET to detect interactions and allosteric modulation. These techniques reveal how one receptor can change the signaling of another, which is relevant to schizophrenia. Functional assays with selective ligands further dissect allosteric effects.
Vascular reactivity and blood pressure measurements
Ex vivo arterial ring assays and in vivo blood pressure telemetry can test whether Gq/11-coupled serotonin receptor-related pathways affect vascular tone. Isoflavone metabolites have been tested in such models, showing arterial relaxation and decreased blood pressure. These physiological methods bridge molecular function to organismal outcomes.
How CRISPR Can Be Used to Study GO:0001587 Gq/11-coupled serotonin receptor activity
Knockout
CRISPR knockout of Gq/11-coupled serotonin receptor genes (e.g., HTR2A, HTR2B, HTR2C) or G protein subunits (GNAQ, GNA11) can abolish the function defined by GO:0001587, providing a clean background to test downstream IP3 and calcium responses. Knockout models are also useful to determine whether constitutive activity contributes to baseline signaling. These models help establish causality between receptor expression and cellular phenotypes.
Point Mutation
Point mutations can be introduced to alter ligand binding, G protein coupling, or constitutive activity of Gq/11-coupled serotonin receptors. Such models allow precise structure-function studies and can mimic disease-associated variants. They are particularly valuable for dissecting the molecular determinants of GO:0001587.
Knock-in
Knock-in of tagged or reporter versions of serotonin receptors enables visualization and tracking of receptor localization and heteromer formation in live cells. This approach can also be used to introduce human disease variants into model systems. Knock-in models are essential for studying allosteric signaling in native contexts.
Overexpression
Overexpression of Gq/11-coupled serotonin receptors or their downstream effectors can amplify signaling and reveal crosstalk with pathways such as HB-EGF/EGFR-ERK1/2-mTOR. These models are useful for identifying novel interacting partners and for drug screening. Overexpression can also unmask constitutive activity that is otherwise masked by low receptor density.
How EDITGENE Supports Gq/11-coupled serotonin receptor activity Research
Researchers studying Gq/11-coupled serotonin receptor activity-related genes often need to determine whether a candidate gene is causally involved in serotonin signaling, metabolic crosstalk, or vascular function. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes associated with GO:0001587.
Contact EDITGENE today to design your custom CRISPR model for Gq/11-coupled serotonin receptor activity research.
Frequently Asked Questions About Gq/11-coupled serotonin receptor activity
What is Gq/11-coupled serotonin receptor activity?
It is a molecular function (GO:0001587) where serotonin binding activates the Gq/11 G protein, leading to phospholipase C activation and increased IP3 levels.
What genes are involved in Gq/11-coupled serotonin receptor activity?
Key genes include HTR2A, HTR2B, HTR2C, GNAQ, GNA11, and PLCB family members, as well as downstream effectors like HBEGF and EGFR.
What is the GO ID for Gq/11-coupled serotonin receptor activity?
The GO ID is GO:0001587.
How does Gq/11-coupled serotonin receptor signaling work?
Serotonin binds the receptor, which activates Gq/11, stimulating phospholipase C to produce IP3 and diacylglycerol, releasing calcium and activating protein kinase C.
What diseases are associated with Gq/11-coupled serotonin receptor activity?
It has been linked to schizophrenia, insulin resistance, and cardiovascular disorders such as hypertension.
Can Gq/11-coupled serotonin receptors signal without serotonin?
Yes, constitutive activity has been observed, enabling signaling even in the absence of agonist and allowing transactivation of co-expressed Gi/o-coupled receptors.
What is the difference between Gq/11-coupled and Gs-coupled serotonin receptors?
Gq/11-coupled receptors activate phospholipase C and increase IP3, while Gs-coupled receptors activate adenylyl cyclase and increase cAMP.
How can I study Gq/11-coupled serotonin receptor activity in the lab?
Common methods include IP3 assays, calcium imaging, phospholipase C activity assays, and downstream kinase Western blots.
What are the research models for Gq/11-coupled serotonin receptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression cell models are widely used to dissect this function.
Why is Gq/11-coupled serotonin receptor activity important for drug discovery?
It is a target for antipsychotics, antidepressants, and cardiovascular drugs, and its crosstalk with growth-factor pathways offers new therapeutic opportunities.
Conclusion
GO:0001587, Gq/11-coupled serotonin receptor activity, is a fundamental molecular function that links serotonin to phospholipase C, IP3, and calcium signaling. Its roles in schizophrenia, insulin resistance, and vascular tone make it a high-value target for both basic and translational research. By leveraging CRISPR-based knockout, point mutation, knock-in, and overexpression models, researchers can precisely dissect the genes and mechanisms underlying this activity. EDITGENE provides the tools and expertise to accelerate discoveries in this field.
References
- 1. Bakker RA et al.. 2004. Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors.. J Biol Chem 279(7):5152-61 PMID: 14610092
- 2. Li Q et al.. 2012. Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.. Endocrinology 153(1):56-68 PMID: 22028447
- 3. Moreno JL et al.. 2016. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.. Sci Signal 9(410):ra5 PMID: 26758213
- 4. Migkos T et al.. 2026. The isoflavone metabolites, O-desmethylangolensin and (S)-equol, relax isolated arteries ex vivo and decrease arterial blood pressure in vivo.. Biochim Biophys Acta Mol Basis Dis 1872(5):168196 PMID: 41720359
